XML 60 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Summary of Revenues Disaggregated by Product Classification and Reportable Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Disaggregation Of Revenue [Line Items]                      
Total revenue $ 22,543 $ 26,883 $ 22,822 $ 22,616 $ 30,816 $ 24,344 $ 22,676 $ 22,241 $ 94,864 $ 100,077 $ 81,336
Product Sales [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 44,317 40,219 37,953
Royalties [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 40,634 48,458 35,424
Research, Development and Other [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 9,913 11,400 7,959
Operating Segments [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 94,864 100,077 81,336
Operating Segments [Member] | Medical Device [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 71,401 78,353 60,513
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 21,608 18,617 17,200
Operating Segments [Member] | Medical Device [Member] | Royalties [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 28,614 34,781 30,606
Operating Segments [Member] | Medical Device [Member] | License Fees [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 12,020 13,678 4,818
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 9,159 11,277 7,889
Operating Segments [Member] | In Vitro Diagnostics [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 23,463 21,724 20,823
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 22,709 21,390 20,789
Operating Segments [Member] | In Vitro Diagnostics [Member] | Other [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 $ 754 $ 334 $ 34